Key Messages of the Iodine Deficiency Working Group (AKJ): Maternal Hypothyroxinemia Due to Iodine Deficiency and Endocrine Disruptors as Risks for Child Neurocognitive Development
Geburtshilfe und Frauenheilkunde · 01.08.2025 · 85 (08) · 796-809
DOI: 10.1055/a-2505-1944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.08.2025. Verfasst von Rolf Grossklaus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mitglied des Wissenschaftlichen Beirats des Arbeitskreises Jodmangel e.V. (AKJ), Frankfurt/Main, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Iodine deficiency with the resultant maternal hypothyroxinemia and the effects of endocrine disruptors can, individually or together, have a negative effect on embryonic and fetal brain development. This is the conclusion of a recent review by the authors which examined and critically discussed a total of 279 publications from the past 30 years on the effects of mild to moderate iodine deficiency, reduced maternal thyroxine levels, and the influence of endocrine disruptors on child brain development during pregnancy. Adequate iodine intake is important for all women of childbearing age to prevent negative psychological and social consequences for their children. An additional threat to the thyroid hormone system is the ubiquitous exposure to endocrine disruptors, which can increase the impact of maternal iodine deficiency on the neurocognitive development of their offspring. Ensuring an adequate iodine intake is therefore not only crucial for healthy fetal and neonatal development in general, but could also prevent the potential effects of endocrine disruptors. Due to the current deficient iodine status of women of childbearing age and of children and adolescents in Germany and most European countries, urgent measures are needed to improve the iodine intake of the population. Therefore, in the opinion of the AKJ, young women of childbearing age should be instructed to take iodine supplements continuously for at least 3 months before conception and during pregnancy. In addition, detailed strategies for detecting and reducing exposure to endocrine disruptors in accordance with the “precautionary principle” should be urgently developed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mitglied des Wissenschaftlichen Beirats des Arbeitskreises Jodmangel e.V. (AKJ), Frankfurt/Main, Germany.
- ehemals Abteilung Lebensmittelsicherheit, Bundesinstitut für Risikobewertung, Berlin, Germany.
- Endokrinologikum Berlin, Zentrum für Hormon- und Stoffwechselerkrankungen, Berlin, Germany.
- Berufsverband der Frauenärzte München, München, Germany.
- Institut für Gemeinschaftsmedizin, SHIP/Klinisch-Epidemiologische Forschung, Universitätsmedizin Greifswald, Greifswald, Germany.
- Medizinische Klinik IV der Universität München, München, Germany.
ORCID-Profile: Rolf Grossklaus
Zitieren
APA
Grossklaus, R., Liesenkötter, K. P., Doubek, K., Völzke, H., & Gaertner, R. (2025). Key Messages of the Iodine Deficiency Working Group (AKJ): Maternal Hypothyroxinemia Due to Iodine Deficiency and Endocrine Disruptors as Risks for Child Neurocognitive Development. Geburtshilfe und Frauenheilkunde, 85(08), 796-809. https://doi.org/10.1055/a-2505-1944
Vancouver
Grossklaus R, Liesenkötter KP, Doubek K, Völzke H, Gaertner R. Key Messages of the Iodine Deficiency Working Group (AKJ): Maternal Hypothyroxinemia Due to Iodine Deficiency and Endocrine Disruptors as Risks for Child Neurocognitive Development. Geburtshilfe und Frauenheilkunde. 2025;85(08):796-809. doi:10.1055/a-2505-1944
BibTeX
@article{Grossklaus2025,
author = {Grossklaus, Rolf and Liesenkötter, Klaus-Peter and Doubek, Klaus and Völzke, Henry and Gaertner, Roland},
title = {Key Messages of the Iodine Deficiency Working Group (AKJ): Maternal Hypothyroxinemia Due to Iodine Deficiency and Endocrine Disruptors as Risks for Child Neurocognitive Development},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2025},
volume = {85},
number = {08},
pages = {796--809},
doi = {10.1055/a-2505-1944}
}
EUVIMED